Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
62.6M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
3.7M
-
Shares change
-
-67.6K
-
Total reported value, excl. options
-
$11.1M
-
Value change
-
-$258K
-
Put/Call ratio
-
0.08
-
Number of buys
-
22
-
Number of sells
-
-20
-
Price
-
$3.01
Significant Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q4 2023
61 filings reported holding IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2023.
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.7M shares
of 62.6M outstanding shares and own 5.91% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (928K shares), RICE HALL JAMES & ASSOCIATES, LLC (572K shares), MAI Capital Management (392K shares), Richmond Brothers, Inc. (253K shares), GEODE CAPITAL MANAGEMENT, LLC (219K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (173K shares), Knoll Capital Management, LLC (100K shares), BlackRock Inc. (94.3K shares), MILLENNIUM MANAGEMENT LLC (85.9K shares), and Diametric Capital, LP (73.3K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.